Showing codes J9217 (Leuprolide acetate (for depot suspension), 7.5 mg) — J9270 (Injection, plicamycin, 2.5 mg)

J9217 - Leuprolide acetate suspnsion
Long description: Leuprolide acetate (for depot suspension), 7.5 mg
Code added date: 19910101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9218 - Leuprolide acetate injeciton
Long description: Leuprolide acetate, per 1 mg
Code added date: 19900101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9219 - Leuprolide acetate implant
Long description: Leuprolide acetate implant, 65 mg
Code added date: 20010101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9220 - Indigotindisulfonate sod 1mg
Long description: Injection, indigotindisulfonate sodium, 1 mg
Code added date: 20250701.
Code effective date: 20250701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9223 - Inj. lurbinectedin, 0.1 mg
Long description: Injection, lurbinectedin, 0.1 mg
Code added date: 20210101.
Code effective date: 20210101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9225 - Vantas implant
Long description: Histrelin implant (vantas), 50 mg
Code added date: 20060101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9226 - Supprelin la implant
Long description: Histrelin implant (supprelin la), 50 mg
Code added date: 20080101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9227 - Inj. isatuximab-irfc 10 mg
Long description: Injection, isatuximab-irfc, 10 mg
Code added date: 20201001.
Code effective date: 20201001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9228 - Ipilimumab injection
Long description: Injection, ipilimumab, 1 mg
Code added date: 20120101.
Code effective date: 20120101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9229 - Inj inotuzumab ozogam 0.1 mg
Long description: Injection, inotuzumab ozogamicin, 0.1 mg
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9230 - Mechlorethamine hcl inj
Long description: Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg
Code added date: 19860101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9245 - Inj melpha hydroch nos 50 mg
Long description: Injection, melphalan hydrochloride, not otherwise specified, 50 mg
Code added date: 19950101.
Code effective date: 20200701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9246 - Inj., evomela, 1 mg
Long description: Injection, melphalan (evomela), 1 mg
Code added date: 20200701.
Code effective date: 20200701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9247 - Inj, melphalan flufenami 1mg
Long description: Injection, melphalan flufenamide, 1mg
Code added date: 20211001.
Code effective date: 20250401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9248 - Inj melphalan (hepzato) 1 mg
Long description: Injection, melphalan (hepzato), 1 mg
Code added date: 20240401.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9249 - Inj, melphalan (apotex) 1 mg
Long description: Injection, melphalan (apotex), 1 mg
Code added date: 20240401.
Code effective date: 20250701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9250 - Methotrexate sodium inj
Long description: Methotrexate sodium, 5 mg
Code added date: 19940101.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9255 - Inj, methotrexate (accord)
Long description: Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg
Code added date: 20240101.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9258 - Paclitaxel (teva)
Long description: Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg
Code added date: 20240101.
Code effective date: 20241001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9259 - Paclitaxel (american regent)
Long description: Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg
Code added date: 20230701.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9260 - Inj methotrexate sodium 50mg
Long description: Injection, methotrexate sodium, 50 mg
Code added date: 19840101.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9261 - Nelarabine injection
Long description: Injection, nelarabine, 50 mg
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9262 - Inj, omacetaxine mep, 0.01mg
Long description: Injection, omacetaxine mepesuccinate, 0.01 mg
Code added date: 20140101.
Code effective date: 20140101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9263 - Oxaliplatin
Long description: Injection, oxaliplatin, 0.5 mg
Code added date: 20040101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9264 - Paclitaxel protein bound
Long description: Injection, paclitaxel protein-bound particles, 1 mg
Code added date: 20060101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9265 - Paclitaxel injection
Long description: Injection, paclitaxel, 30 mg
Code added date: 19940101.
Code effective date: 20150101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9266 - Pegaspargase injection
Long description: Injection, pegaspargase, per single dose vial
Code added date: 19960101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9267 - Paclitaxel injection
Long description: Injection, paclitaxel, 1 mg
Code added date: 20150101.
Code effective date: 20150101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9268 - Pentostatin injection
Long description: Injection, pentostatin, 10 mg
Code added date: 19940101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9269 - Inj. tagraxofusp-erzs 10 mcg
Long description: Injection, tagraxofusp-erzs, 10 micrograms
Code added date: 20191001.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9270 - Plicamycin (mithramycin) inj
Long description: Injection, plicamycin, 2.5 mg
Code added date: 19840101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF